Hematology TimesTeam discovers mechanism of resistance in AMLNovember 18, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology NewsUniversal paternal Rh screening is cost effective in IVFNovember 17, 2017Transfusion Medicine
Hematology NewsFDA approves obinutuzumab for follicular lymphomaNovember 17, 2017Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsRestrictive transfusion strategy safe in cardiac surgeryNovember 17, 2017Transfusion Medicine
Oncology PracticeFDA approves sunitinib malate as adjuvant treatment for RCCNovember 17, 2017Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeFDA authorizes next-generation sequencing test for tumor profilingNovember 17, 2017Immuno-oncologyTranslational Research
Hematology TimesProduct approved to treat patients with hemophilia A and inhibitorsNovember 17, 2017ThrombosisPharmacyBleeding Disorders
Hematology TimesFDA expands approval of obinutuzumabNovember 17, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology NewsFDA addresses cell-based regenerative medicine in comprehensive new policyNovember 16, 2017Business of MedicinePractice ManagementCellular Therapy
Hematology NewsPrescribers mostly ignore clopidogrel pharmacogenomic profilingNovember 16, 2017Thrombosis
Hematology NewsRituximab key to survival after transplant for mantle cell lymphomaNovember 16, 2017Mantle Cell LymphomaLymphoma & Plasma Cell DisordersAggressive Lymphomas
Hematology TimesRigosertib produces better OS in MDS than tAMLNovember 16, 2017AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hematology TimesFDA approves generic clofarabineNovember 16, 2017Leukemia, Myelodysplasia, TransplantationPharmacyALL
